Because of limited, incomplete or no data on the clinical impact of ERCC1 (rs11615, rs3212986) and TOP2A (rs13695, rs34300454, rs11540720) polymorphisms in NSCLC we decided to examined their influence on the efficiency and toxicity of platinum‐based chemotherapy. This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.